Prognostic Value of Cardiac Troponin I Measured With a Highly Sensitive Assay in Patients With Stable Coronary Artery Disease

被引:274
作者
Omland, Torbjorn [1 ,2 ,3 ]
Pfeffer, Marc A. [4 ,5 ]
Solomon, Scott D. [4 ,5 ]
de Lemos, James A. [6 ]
Rosjo, Helge [1 ,2 ,3 ]
Benth, Jurate Saltyte [7 ,8 ]
Maggioni, Aldo [9 ]
Domanski, Michael J. [10 ]
Rouleau, Jean L. [11 ,12 ]
Sabatine, Marc S. [4 ,5 ]
Braunwald, Eugene [4 ,5 ]
机构
[1] Akershus Univ Hosp, Div Med, Dept Cardiol, NO-1478 Lorenskog, Norway
[2] Univ Oslo, Ctr Heart Failure Res, Oslo, Norway
[3] Univ Oslo, KG Jebsen Cardiac Res Ctr, Oslo, Norway
[4] Harvard Univ, Sch Med, Dept Med, Boston, MA USA
[5] Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA
[6] Univ Texas SW Med Ctr Dallas, Div Cardiol, Dallas, TX 75390 USA
[7] Akershus Univ Hosp, HOKH Res Ctr, NO-1478 Lorenskog, Norway
[8] Univ Oslo, Inst Clin Med, Oslo, Norway
[9] Ctr Studi ANMCO, Florence, Italy
[10] Mt Sinai Sch Med, New York, NY USA
[11] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada
[12] Univ Montreal, Fac Med, Montreal, PQ H3C 3J7, Canada
关键词
cardiovascular death; coronary artery disease; natriuretic peptides; troponin; MYOCARDIAL-ISCHEMIA; HEART-FAILURE; T ASSAY; MORTALITY; RISK; ASSOCIATION; RELEASE; SERUM;
D O I
10.1016/j.jacc.2012.12.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The aims of this study were to assess the prognostic value of cardiac troponin I levels, measured with a new high-sensitivity assay, in low-risk patients with stable coronary artery disease (CAD) and to contrast its determinants and prognostic merit with that of high-sensitivity cardiac troponin T (hs-TnT). Background New, highly sensitive cardiac troponin assays permit evaluation of the association between troponin levels and outcomes in patients with stable CAD. Methods High-sensitivity cardiac troponin I (hs-TnI) levels at baseline were assessed in 3,623 patients with stable CAD and preserved systolic function enrolled in the PEACE (Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy) trial. Results In total, 98.5% of patients had hs-TnI concentrations higher than the detection level (1.2 pg/ml). hs-TnI correlated moderately with hs-TnT (r = 0.44) and N-terminal pro-B-type natriuretic peptide (r = 0.39) but only weakly with age (r = 0.17) and estimated glomerular filtration rate (r = -0.11). During a median follow-up period of 5.2 years, 203 patients died of cardiovascular causes or were hospitalized for heart failure, and 209 patients had nonfatal myocardial infarctions. In analyses adjusting for conventional risk markers, N-terminal pro-B-type natriuretic peptide, and hs-TnT, hs-TnI levels in the fourth compared with the 3 lower quartiles were associated with the incidence of cardiovascular death or heart failure (hazard ratio: 1.88; 95% confidence interval: 1.33 to 2.66; p < 0.001). There was a significant, albeit weaker association with nonfatal myocardial infarction (hazard ratio: 1.44; 95% confidence interval: 1.03 to 2.01; p = 0.031). In the same models, hs-TnT concentrations were associated with the incidence of cardiovascular death or heart failure but not of myocardial infarction. Conclusions In patients with stable CAD, hs-TnI concentrations are associated with cardiovascular risk independently of conventional risk markers and hs-TnT. (Prevention of Events With Angiotensin-Converting Enzyme Inhibitor Therapy [PEACE]; NCT00000558) (J Am Coll Cardiol 2013;61:1240-9) (C) 2013 by the American College of Cardiology Foundation
引用
收藏
页码:1240 / 1249
页数:10
相关论文
共 26 条
[1]   2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction [J].
Anderson, Jeffrey L. ;
Adams, Cynthia D. ;
Antman, Elliott M. ;
Bridges, Charles R. ;
Califf, Robert M. ;
Casey, Donald E., Jr. ;
Chavey, William E. ;
Fesmire, Francis M. ;
Hochman, Judith S. ;
Levin, Thomas N. ;
Lincoff, A. Michael ;
Peterson, Eric D. ;
Theroux, Pierre ;
Wenger, Nanette Kass ;
Wright, R. Scott ;
Wright, R. Scott ;
Anderson, Jeffrey L. ;
Adams, Cynthia D. ;
Bridges, Charles R. ;
Casey, Donald E., Jr. ;
Ettinger, Steven M. ;
Fesmire, Francis M. ;
Ganiats, Theodore G. ;
Jneid, Hani ;
Lincoff, A. Michael ;
Peterson, Eric D. ;
Philippides, George J. ;
Theroux, Pierre ;
Wenger, Nanette K. ;
Zidar, James Patrick ;
Jacobs, Alice K. ;
Anderson, Jeffrey L. ;
Albert, Nancy ;
Hochman, Judith S. ;
Creager, Mark A. ;
Kushner, Frederick G. ;
Ettinger, Steven M. ;
Ohman, Erik Magnus ;
Guyton, Robert A. ;
Stevenson, William G. ;
Halperin, Jonathan L. ;
Yancy, Clyde W. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (19) :E215-E367
[2]   Determination of 19 Cardiac Troponin I and T Assay 99th Percentile Values from a Common Presumably Healthy Population [J].
Apple, Fred S. ;
Ler, Ranka ;
Murakami, MaryAnn M. .
CLINICAL CHEMISTRY, 2012, 58 (11) :1574-1581
[3]  
Braunwald E, 2004, NEW ENGL J MED, V351, P2058
[4]   Association of Troponin T Detected With a Highly Sensitive Assay and Cardiac Structure and Mortality Risk in the General Population [J].
de Lemos, James A. ;
Drazner, Mark H. ;
Omland, Torbjorn ;
Ayers, Colby R. ;
Khera, Amit ;
Rohatgi, Anand ;
Hashim, Ibrahim ;
Berry, Jarett D. ;
Das, Sandeep R. ;
Morrow, David A. ;
McGuire, Darren K. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (22) :2503-2512
[5]   Association of Serial Measures of Cardiac Troponin T Using a Sensitive Assay With Incident Heart Failure and Cardiovascular Mortality in Older Adults [J].
deFilippi, Christopher R. ;
de Lemos, James A. ;
Christenson, Robert H. ;
Gottdiener, John S. ;
Kop, Willem J. ;
Zhan, Min ;
Seliger, Stephen L. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (22) :2494-2502
[6]  
Feng J, 2001, CIRCULATION, V103, P2035
[7]   Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation [J].
Hessel, M. H. M. ;
Atsma, D. E. ;
van der Valk, E. J. M. ;
Bax, W. H. ;
Schalij, M. J. ;
van der Laarse, A. .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2008, 455 (06) :979-986
[8]   High-Sensitivity Cardiac Troponin I Measurement for Risk Stratification in a Stable High-Risk Population [J].
Kavsak, Peter A. ;
Xu, Liqin ;
Yusuf, Salim ;
McQueen, Matthew J. .
CLINICAL CHEMISTRY, 2011, 57 (08) :1146-1153
[9]   Determinants of troponin release in patients with stable coronary artery disease: insights from CT angiography characteristics of atherosclerotic plaque [J].
Korosoglou, Grigorios ;
Lehrke, Stephanie ;
Mueller, Dirk ;
Hosch, Waldemar ;
Kauczor, Hans-Ulrich ;
Humpert, Per M. ;
Giannitsis, Evangelos ;
Katus, Hugo A. .
HEART, 2011, 97 (10) :823-831
[10]   Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction [J].
Labugger, R ;
Organ, L ;
Collier, C ;
Atar, D ;
Van Eyk, JE .
CIRCULATION, 2000, 102 (11) :1221-1226